imatinib mesylate has been researched along with Psoriasis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egusa, C; Harada, K; Hayakawa, K; Maeda, T; Okubo, Y | 1 |
| Gu, Y; Li, K; Zhang, J; Zhou, Y | 1 |
| Ambrifi, M; Bottoni, U; Calvieri, S; Clerico, R; Corsetti, P; Didona, D; Paolino, G | 1 |
| Cheng, H; Geist, DE; Piperdi, B; Piperdi, M; Virk, R | 1 |
| Bienz, N; Dickens, E; Lewis, F | 1 |
| Thachil, J | 1 |
| Martin, L | 1 |
| Fujimoto, H; Hirota, S; Kitamura, Y; Ko, S; Miyagawa, S | 1 |
| Akiyama, T; Fujimi, A; Kida, M; Kuroda, H; Matsunaga, T; Niitsu, Y; Sato, T; Shimizu, K; Shirao, S; Tanaka, I; Watanabe, H | 1 |
| Huh, CH; Park, KC; Woo, SM; Youn, SW | 1 |
1 review(s) available for imatinib mesylate and Psoriasis
| Article | Year |
|---|---|
[What's new in dermatological treatments?].
Topics: Adenine; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclosporine; Dermatofibrosarcoma; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Follow-Up Studies; Gels; HIV Infections; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Ipilimumab; Melanoma; Neoplasm Staging; Organophosphonates; Piperazines; Psoriasis; Pyrimidines; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Survival Analysis; Tenofovir; Treatment Outcome; Ustekinumab | 2010 |
9 other study(ies) available for imatinib mesylate and Psoriasis
| Article | Year |
|---|---|
Topical application of imatinib mesylate ameliorated psoriasis-like skin lesions in imiquimod-induced murine model via angiogenesis inhibition.
Topics: Animals; Disease Models, Animal; Humans; Imatinib Mesylate; Imiquimod; Keratinocytes; Mice; Mice, Inbred BALB C; Psoriasis; Skin; Skin Diseases; Vascular Endothelial Growth Factor A | 2023 |
Chronic myeloid leukaemia in a patient with psoriasis following bimolane treatment.
Topics: Antineoplastic Agents; Dermatologic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Psoriasis; Razoxane | 2020 |
Skin lesions in patients treated with imatinib mesylate: a 5-year prospective study.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Dermatitis, Seborrheic; Dermatomycoses; Drug Eruptions; Eczema; Edema; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Histiocytoma, Benign Fibrous; Humans; Imatinib Mesylate; Keratosis, Actinic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Orbital Diseases; Prospective Studies; Pruritus; Psoriasis; Skin Neoplasms | 2016 |
Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Drug Eruptions; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Methotrexate; Middle Aged; Peritoneal Neoplasms; Piperazines; Psoriasis; Pyrimidines; Treatment Outcome | 2009 |
Imatinib: a designer drug, another cutaneous complication.
Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Piperazines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines | 2009 |
T-regulatory cell response in psoriasis and changes with imatinib therapy.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Immunity, Cellular; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Psoriasis; Pyrimidines; T-Lymphocytes, Regulatory | 2009 |
Improvement of psoriasis during imatinib therapy in a patient with a metastatic gastrointestinal stromal tumour.
Topics: Benzamides; Colonic Neoplasms; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Piperazines; Protein-Tyrosine Kinases; Psoriasis; Pyrimidines; Splenic Neoplasms | 2002 |
[Psoriasis vulgaris exacerbated by imatinib therapy in chronic myelogenous leukemia].
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Count; Male; Middle Aged; Piperazines; Psoriasis; Pyrimidines; Th1 Cells | 2005 |
Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Psoriasis; Pyrimidines; Skin | 2007 |